Chen Xu
Chongqing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
ABCB1-mediated docetaxel resistance reversed by erastin in prostate cancer.
Journal: The FEBS journal
Published: September 28, 2023
Carvedilol induces pyroptosis through NLRP3-caspase1-ASC inflammasome by nuclear migration of NF-κB in prostate cancer models.
Journal: Molecular biology reports
Published: September 18, 2023
Inhibition of β2-adrenergic receptor regulates necroptosis in prostate cancer cell.
Journal: Heliyon
Published: June 30, 2023
Sympathetic β2-adrenergic receptor blockade overcomes docetaxel resistance in prostate cancer.
Journal: Biochemical and biophysical research communications
Published: February 18, 2023
Autophagy Induced by Muscarinic Acetylcholine Receptor 1 Mediates Migration and Invasion Targeting Atg5 via AMPK/mTOR Pathway in Prostate Cancer.
Journal: Journal of oncology
Published: April 19, 2021
β2 -adrenergic receptor signaling drives prostate cancer progression by targeting the Sonic hedgehog-Gli1 signaling activation.
Journal: The Prostate
Published: February 04, 2020
Muscarinic acetylcholine receptor M1 mediates prostate cancer cell migration and invasion through hedgehog signaling.
Journal: Asian journal of andrology
Published: July 21, 2018
AZD5153 Inhibits Prostate Cancer Cell Growth in Vitro and in Vivo.
Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Published: January 19, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026